CBLIF and Cirrhosis: Severe disease (presence of cirrhosis), experience of Peg-INF or conventional INF, RBV and NS5A associated resistance associated substitutions (RASs) are predictors of relapse in HCV GT-3.10 These factors also contribute to non-response.